Nuvaxovid™ COVID-19 vaccine is the first protein-based option for adolescents aged 12 through 17 in Europe GAITHERSBURG, Md., July 5, 2022 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious…
Related Posts
-
PIC AU HOLDINGS LLC AND PIC AU HOLDINGS CORPORATION, WHOLLY-OWNED SUBSIDIARIES OF PEABODY, ANNOUNCE AN UPSIZE OF THEIR PREVIOUSLY ANNOUNCED OFFER TO PURCHASE THEIR 10.000% SENIOR SECURED NOTES DUE 2024 TO $90 MILLION AGGREGATE PRINCIPAL AMOUNT, A RELATED EXTENSION OF THE OFFER’S EXPIRATION DATE, AND AN OFFER TO REPURCHASE ADDITIONAL TERM LOAN DEBT Uncategorized